Communicable E17: Season’s greetings from the editors & holiday replay of late-breaker clinical trials at ESCMID Global 2024
The last episode of the year carries a special end-of-year message from the CMI Comms editors and replays the very first episode of Communicable aired on 10 May 2024, in which editors Angela Huttner, ...
29 Des 20241h 4min
Communicable E16: Climate change and infections – effects on clinical practice & sustainability
The topic of climate change can engender a ‘doom and gloom’ narrative, as many climate and health consequences are already manifesting. Our host, Dr. Navaneeth Narayanan is joined by two ID physicians...
15 Des 202450min
Communicable E15: Wastewater surveillance – can it really protect us from infections?
Wastewater surveillance is a powerful epidemiological tool that “mirrors our life,” and has gained wide attention in recent years due to its application during the COVID-19 pandemic. The hosts this we...
1 Des 202454min
Communicable E14 - Substandard and falsified antimicrobials: what is their effect on patients and on AMR?
Substandard and falsified (SF) antimicrobials are a neglected global health problem and have been implicated as drivers of antimicrobial resistance (AMR). Substandard medicines are authorized medical ...
18 Nov 202452min
Communicable E13 - The Wild West of publishing today: predatory journals and how to deal with them
The market of predatory publishing is as lucrative as it is unethical. Predatory journals are disguised as legitimate entities, and prey on both early-career academics and the naïve. In this episode o...
4 Nov 202446min
Communicable E12 - The Nightmare Series, part 3: How to deal with vancomycin-resistant enterococci
Enterococci are commensal microbes, part of the healthy microflora populating the human gut. But they are also opportunistic pathogens and notorious nosocomial agents with intrinsic traits that promot...
21 Okt 202457min
Communicable E11 - Nightmare series, part 2: How to deal with carbapenemase producers
Carbapenemase producers are a nightmare for clinicians. Not only are they resistant to carbapenems, a last resort β-lactam antibiotic, they are notorious for developing multidrug and pandrug resistanc...
7 Okt 20241h
Communicable E10 - Pipeline update: new antibiotics & other antimicrobials that you might actually use
On the verge of a post-antibiotic reality, there is an urgent clinical need for new antibiotics. Luckily, new candidates are in the pipeline and older agents are getting a second breath of life throug...
23 Sep 202452min
